tiprankstipranks
Trending News
More News >
Rani Therapeutics Holdings (RANI)
NASDAQ:RANI
US Market

Compare Rani Therapeutics Holdings (RANI) vs. Competitors

Compare
1,513 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Rani Therapeutics Holdings
$1.39
$167.70M
-1.76
-2.80%
3 Buy
0 Hold
0 Sell
Strong Buy
Tenax Therapeutics
$12.85
$82.85M
-11.33
100.47%
4 Buy
0 Hold
0 Sell
Strong Buy
Iterum Therapeutics
$0.29
$18.50M
-0.48
-80.80%
2 Buy
0 Hold
0 Sell
Moderate Buy
Annovis Bio
$4.07
$102.04M
-2.74
-19.41%
2 Buy
0 Hold
0 Sell
Moderate Buy
PolyPid
$4.77
$72.65M
-1.60
52.40%
3 Buy
0 Hold
0 Sell
Strong Buy
AN2 Therapeutics, Inc.
$1.09
$29.32M
-0.97
-18.52%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
RANI
Rani Therapeutics Holdings
1.39
0.14
11.20%
TENX
Tenax Therapeutics
12.85
6.61
105.93%
ITRM
Iterum Therapeutics
0.36
-1.44
-80.06%
ANVS
Annovis Bio
4.07
-0.82
-16.77%
PYPD
PolyPid
4.77
1.67
53.87%
ANTX
AN2 Therapeutics, Inc.
1.10
-0.15
-12.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts